Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metoclopramide hydrochloride |
Is a |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Metoclopramide measurement |
Component |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide poisoning |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Accidental metoclopramide poisoning |
Causative agent (attribute) |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Intentional metoclopramide poisoning (disorder) |
Causative agent (attribute) |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
intoxication par la métoclopramide d'intention indéterminée |
Causative agent (attribute) |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide adverse reaction |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Allergy to metoclopramide (finding) |
Causative agent (attribute) |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Metoclopramide overdose |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Accidental metoclopramide overdose |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Intentional metoclopramide overdose |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
surdose de métoclopramide d'intention indéterminée |
Causative agent (attribute) |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing metoclopramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and metoclopramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing metoclopramide and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Accidental metoclopramide poisoning |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Intentional metoclopramide poisoning (disorder) |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Allergy to metoclopramide (finding) |
Causative agent (attribute) |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
|
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and metoclopramide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing only aspirin and metoclopramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing only metoclopramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing only metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing only aspirin and metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Product containing only metoclopramide in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide (substance) |
Inferred relationship |
Some |
1 |